참고문헌
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424 https://doi.org/10.3322/caac.21492
- Jung KW, Won YJ, Kong HJ, Lee ES; Community of Population-Based Regional Cancer Registries. Cancer Statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat 2018;50:303-316 https://doi.org/10.4143/crt.2018.143
- Park EH, Min SY, Kim Z, Yoon CS, Jung KW, Nam SJ, et al. Basic facts of breast cancer in Korea in 2014: the 10-year overall survival progress. J Breast Cancer 2017;20:1-11 https://doi.org/10.4048/jbc.2017.20.1.1
- Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, et al. Extending aromatase-inhibitor adjuvant therapy to 10 years. N Engl J Med 2016;375:209-219 https://doi.org/10.1056/NEJMoa1604700
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7-34 https://doi.org/10.3322/caac.21551
- Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 2007;608:1-22 https://doi.org/10.1007/978-0-387-74039-3_1
- Soerjomataram I, Louwman MW, Ribot JG, Roukema JA, Coebergh JW. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 2008;107:309-330 https://doi.org/10.1007/s10549-007-9556-1
- Hatteville L, Mahe C, Hill C. Prediction of the long-term survival in breast cancer patients according to the present oncological status. Stat Med 2002;21:2345-2354 https://doi.org/10.1002/sim.1046
- Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE Jr, Jeong JH, Tan-Chiu E, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 2006;24:2028-2037 https://doi.org/10.1200/JCO.2005.04.3273
- Mansell J, Monypenny IJ, Skene AI, Abram P, Carpenter R, Gattuso JM, et al. Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer. Breast Cancer Res Treat 2009;117:91-98 https://doi.org/10.1007/s10549-008-0291-z
- Payandeh M, Sadeghi M, Sadeghi E. Differences in prognostic factors between early and late recurrence breast cancers. Asian Pac J Cancer Prev 2015;16:6575-6579 https://doi.org/10.7314/APJCP.2015.16.15.6575
- Neri A, Marrelli D, Rossi S, De Stefano A, Mariani F, De Marco G, et al. Breast cancer local recurrence: risk factors and prognostic relevance of early time to recurrence. World J Surg 2007;31:36-45 https://doi.org/10.1007/s00268-006-0097-2
- Courdi A, Largillier R, Ferrero JM, Lallement M, Raoust I, Ettore F, et al. Early versus late local recurrences after conservative treatment of breast carcinoma: differences in primary tumor characteristics and patient outcome. Oncology 2006;71:361-368 https://doi.org/10.1159/000107771
- Nishimura R, Osako T, Nishiyama Y, Tashima R, Nakano M, Fujisue M, et al. Evaluation of factors related to late recurrence--later than 10 years after the initial treatment--in primary breast cancer. Oncology 2013;85:100-110 https://doi.org/10.1159/000353099
- Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015;26 Suppl 5:v8-v30 https://doi.org/10.1093/annonc/mdv298
- Kennecke H, McArthur H, Olivotto IA, Speers C, Bajdik C, Chia SK, et al. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen. Cancer 2008;112:1437-1444 https://doi.org/10.1002/cncr.23320
- Lee KK, Kim JY, Jung JH, Park JY, Park HY. Clinicopathological feature and recurrence pattern of triple negative breast cancer. J Korean Surg Soc 2010;79:14-19 https://doi.org/10.4174/jkss.2010.79.1.14
- Song WJ, Kim KI, Park SH, Kwon MS, Lee TH, Park HK, et al. The risk factors influencing between the early and late recurrence in systemic recurrent breast cancer. J Breast Cancer 2012;15:218-223 https://doi.org/10.4048/jbc.2012.15.2.218
- Fitzpatrick DJ, Lai CS, Parkyn RF, Walters D, Humeniuk V, Walsh DC. Time to breast cancer relapse predicted by primary tumour characteristics, not lymph node involvement. World J Surg 2014;38:1668-1675 https://doi.org/10.1007/s00268-013-2397-7
- Choi EJ, Choi H, Choi SA, Youk JH. Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer. Medicine (Baltimore) 2016;95:e5330
- D'Orsi CJ. ACR BI-RADS atlas: breast imaging reporting and data system. Reston: American College of Radiology 2013
- Shaikh T, Tam TY, Li T, Hayes SB, Goldstein L, Bleicher R, et al. Multifocal and multicentric breast cancer is associated with increased local recurrence regardless of surgery type. Breast J 2015;21:121-126 https://doi.org/10.1111/tbj.12366
- Lang Z, Wu Y, Li C, Li X, Wang X, Qu G. Multifocal and multicentric breast carcinoma: a significantly more aggressive tumor than unifocal breast cancer. Anticancer Res 2017;37:4593-4598
- Bae MS, Chang JM, Cho N, Han W, Ryu HS, Moon WK. Association of preoperative breast MRI features with locoregional recurrence after breast conservation therapy. Acta Radiol 2018;59:409-417 https://doi.org/10.1177/0284185117723041
- Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6 https://doi.org/10.1093/jnci/82.1.4
- Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29:15-18 https://doi.org/10.1053/sonc.2002.37263
- Heimann R, Ferguson D, Gray S, Hellman S. Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis. Breast Cancer Res Treat 1998;52:147-158 https://doi.org/10.1023/A:1006123520603
- Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8 https://doi.org/10.1056/NEJM199101033240101
- Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755-761 https://doi.org/10.1016/0046-8177(92)90344-3
- Leek RD, Landers RJ, Harris AL, Lewis CE. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999;79:991-995 https://doi.org/10.1038/sj.bjc.6690158
- Hasebe T, Tsuda H, Hirohashi S, Shimosato Y, Tsubono Y, Yamamoto H, et al. Fibrotic focus in infiltrating ductal carcinoma of the breast: a significant histopathological prognostic parameter for predicting the longterm survival of the patients. Breast Cancer Res Treat 1998;49:195-208 https://doi.org/10.1023/A:1006067513634
- Lee SH, Cho N, Kim SJ, Cha JH, Cho KS, Ko ES, et al. Correlation between high resolution dynamic MR features and prognostic factors in breast cancer. Korean J Radiol 2008;9:10-18 https://doi.org/10.3348/kjr.2008.9.1.10
- Jinguji M, Kajiya Y, Kamimura K, Nakajo M, Sagara Y, Takahama T, et al. Rim enhancement of breast cancers on contrast-enhanced MR imaging: relationship with prognostic factors. Breast Cancer 2006;13:64-73 https://doi.org/10.2325/jbcs.13.64